US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Sanofi SA

52.76

+0.44000.84%

Pre-market: 52.760.00000.00%08:02 EDT

Volume:2.00M

Turnover:105.97M

Market Cap:129.16B

PE:19.35

High:53.15

Open:52.76

Low:52.69

Close:52.32

Loading ...

Overview Company News Filings

Sanofi's 21-Valent Pneumococcal Vaccine Enters Phase III

Sanofi’s Tolebrutinib Receives FDA Breakthrough Therapy Designation for nrSPMS

Pharma Stock Roundup: PFE's 2025 Outlook, MRK & ABBV's M&A Deals

Sanofi to acquire rights to develop, commercialize aficamten from Corxel

Cytokinetics Says Sanofi Acquiring Rights for Aficamten in Greater China

MT Newswires Live

European Equities Traded in the US as American Depositary Rise in Wednesday Trading

MT Newswires Live

Merck's BLA for RSV Antibody Clesrovimab Gets FDA Acceptance

SNY, TEVA Stocks Jump on Encouraging Data From IBD Drug Study

Strength Seen in Sanofi (SNY): Can Its 6.7% Jump Turn into More Strength?

Equity Markets Fall as Fed Meeting Gets Underway

MT Newswires Live

Teva and Sanofi (SNY) Jump amid Impressive Drug Results

Sector Update: Health Care Stocks Mixed Tuesday Afternoon

MT Newswires Live

Update: Teva, Sanofi Shares Jump as Phase 2B Duvakitug Study Meets Primary Endpoints in Inflammatory Bowel Disease

MT Newswires Live

Teva Stock Soars 19% as Game-Changing IBD Drug Duvakitug Crushes Trial Expectations

Teva Shares Soar on Early Bowel Disease Drug Data -- Barrons.com

Why Are Teva And Sanofi Stocks Trading Higher On Tuesday?

Teva, Sanofi Say Phase 2B Duvakitug Study Meets Primary Endpoints in Inflammatory Bowel Disease

MT Newswires Live

Pre-Bell｜U.S. Futures Dip; Tesla Gains 2%; Nvidia Drops 2%; Palantir Sinks 3%; Quantum Stocks Shine

Tiger Newspress

Teva, Sanofi Say IBD Treatment Achieved Higher Remission at Trial

Teva, Sanofi Say Drug to Treat IBD Met Primary Targets

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Trading app for stocks, options & ETFs","description":"Invest in US, ASX, HK, China A-shares, ETFs & options with Tiger Brokers, Australia's trusted stock trading app!","keywords":"tiger brokers,tiger brokers au,tiger brokers australia,tiger trade,tiger trading,australia stock platform,US option,US stocks,stocks and options,australian trading platform,online broker australia,stock trading apps,mobile trading app,desktop trading,chess sponsored brokers,share trading platform","social":{"ogDescription":"Invest in US, ASX, HK, China A-shares, ETFs & options with Tiger Brokers, Australia's trusted stock trading app!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/SNY/news?page=9"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"AUS","license":"TBAU","edition":"fundamental","symbol":"SNY","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SNY\",,,,,undefined,":{"symbol":"SNY","market":"US","secType":"STK","nameCN":"Sanofi SA","latestPrice":52.76,"timestamp":1745870400000,"preClose":52.32,"halted":0,"volume":2004844,"hourTrading":{"tag":"盘前","latestPrice":52.76,"preClose":52.76,"latestTime":"08:02 EDT","volume":7177,"amount":381474.975756,"timestamp":1745928125438},"delay":0,"floatShares":2205948514,"shares":2448069980,"eps":2.726027,"marketStatus":"Pre-Mkt","change":0.44,"latestTime":"04-29 08:02:12 EDT","open":52.76,"high":53.15,"low":52.69,"amount":105969870.020018,"amplitude":0.008792,"askPrice":53.15,"askSize":2400,"bidPrice":53.11,"bidSize":1500,"shortable":3,"etf":0,"ttmEps":2.726027,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1745933400000},"marketStatusCode":1,"adr":1,"adrRate":0.5,"listingDate":1025496000000,"exchange":"NASDAQ","adjPreClose":52.76,"dividendRate":0.038609,"preHourTrading":{"tag":"盘前","latestPrice":52.76,"preClose":52.76,"latestTime":"08:02 EDT","volume":7177,"amount":381474.975756,"timestamp":1745928125438},"postHourTrading":{"tag":"盘后","latestPrice":52.77,"preClose":52.76,"latestTime":"16:44 EDT","volume":10924,"amount":576353.18,"timestamp":1745873040503},"volumeRatio":0.5091545627022415,"impliedVol":0.3144,"impliedVolPercentile":0.7871},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SNY\",,,,,undefined,":{"symbol":"SNY","floatShares":2205948514,"roa":"4.28%","roe":"7.30%","lyrEps":2.29994,"volumeRatio":0.5091545627022415,"shares":2448069980,"dividePrice":2.037,"high":53.15,"amplitude":0.008792,"preClose":52.32,"low":52.69,"week52Low":45.8,"pbRate":"1.46","psRate":"2.51","week52High":60.115,"institutionHeld":0.0837,"latestPrice":52.76,"committee":-0.230769,"eps":2.726027,"divideRate":0.038609,"volume":2004844,"delay":0,"ttmEps":2.726027,"open":52.76,"prevYearClose":48.23,"prevWeekClose":52.32,"prevMonthClose":55.46,"prevQuarterClose":55.46,"fiveDayClose":50.93,"twentyDayClose":55.82,"sixtyDayClose":54.15},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"SNY\",pageSize:20,pageCount:9,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2493779256","title":"Sanofi's 21-Valent Pneumococcal Vaccine Enters Phase III","url":"https://stock-news.laohu8.com/highlight/detail?id=2493779256","media":"Zacks","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2493779256?lang=en_us&edition=fundamental","pubTime":"2024-12-24 01:42","pubTimestamp":1734975720,"startTime":"0","endTime":"0","summary":"Sanofi SNY and its partner SK bioscience announced that they have expanded their agreement to develop, license and commercialize next-generation pneumococcal conjugate vaccines  for treating invasive pneumococcal disease  in pediatric and adult patient populations.The latest deal builds on the existing collaboration between SNY and SK bioscience to develop and commercialize a 21-valent PCV  for the pediatric patient population.Sanofi also said that the companies commenced a phase III program for the PCV21 pediatric vaccine last week. Per management, this is the first-ever PCV containing more than 20 serotypes to enter a phase III study targeting infants and toddlers.Year to date, shares of Sanofi have lost 4% against the industry’s growth of 1.4%.Per the expanded collaboration agreement, Sanofi and SK bioscience will jointly fund all research and development costs to support the launch of PCV21 and next-generation vaccines.Pfizer PFE is a key player in the PCV vaccine space.Small vacci","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/MPLv._QOfr9ekgf5qyZbUA--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/4c89fa4c828d913dc49739912177a966","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/MPLv._QOfr9ekgf5qyZbUA--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/4c89fa4c828d913dc49739912177a966"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/sanofis-21-valent-pneumococcal-vaccine-174200443.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4585","IE0002270589.USD","LU1974910355.USD","LU0306806265.USD","III","LU0211331839.USD","LU1989771016.USD","LU2106854487.HKD","BK4139","SNYNF","LU0058720904.USD","LU1116320737.USD","SG9999014575.USD","SGXZ57979304.SGD","IE00BN8TJ469.HKD","LU1989772840.SGD","LU2361045086.USD","IE00BBT3K403.USD","PFE","LU0203347892.USD","PCVX","LU2468319806.SGD","LU0070302665.USD","SG9999013999.USD","LU1116320901.HKD","BK4550","LU1037948897.HKD","LU0456855351.SGD","LU0225771236.USD","LU1430594728.SGD","LU2361044949.HKD","LU0225284248.USD","MRK","IE00BJT1NW94.SGD","LU1066051498.USD","LU2089984988.USD","LU0289739699.SGD","BK4592","LU0053671581.USD","LU0861579265.USD","LU2361044865.SGD","SG9999001176.SGD","LU0306807586.USD","LU0265550946.USD","LU1057294990.SGD","LU1093756325.SGD","LU0320765489.SGD","SNY","LU1061106388.HKD","LU0965508806.USD"],"gpt_icon":1},{"id":"2493237656","title":"Sanofi’s Tolebrutinib Receives FDA Breakthrough Therapy Designation for nrSPMS","url":"https://stock-news.laohu8.com/highlight/detail?id=2493237656","media":"TipRanks","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2493237656?lang=en_us&edition=fundamental","pubTime":"2024-12-21 19:28","pubTimestamp":1734780538,"startTime":"0","endTime":"0","summary":"Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks. Sanofi announced that the FDA has granted Breakthrough Therapy designation to tolebrutinib for treating non-relapsing secondary progressive multiple sclerosis . This designation follows positive results from the HERCULES phase 3 study, which showed tolebrutinib’s potential in delaying disability progression, addressing a significant unmet need in multiple sclerosis treatment. The designation aims to expedite the development of tolebrutinib, which is notable as there are currently no approved treatments for nrSPMS. Regulatory submissions are being finalized, and further studies are ongoing, indicating Sanofi’s continued efforts to enhance its positioning in the neurology field.Sanofi is a global healthcare company focused on transforming the practice of medicine with innovative treatments and life-saving vaccines. It is commit","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/tXfTVJ1OixCCbB5e.FsdJg--~B/aD0xOTI7dz0xOTI7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/tipranks_452/38a68defd725ddd544390055e985cfb8","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/tXfTVJ1OixCCbB5e.FsdJg--~B/aD0xOTI7dz0xOTI7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/tipranks_452/38a68defd725ddd544390055e985cfb8"],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/sanofi-tolebrutinib-receives-fda-breakthrough-112858471.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/sanofi-tolebrutinib-receives-fda-breakthrough-112858471.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE00B1BXHZ80.USD","LU1582987597.SGD","LU1301847155.USD","LU2237443465.HKD","SNY","IE0009356076.USD","LU1066051225.USD","LU1989764664.SGD","SNYNF","LU0251132253.USD","IE00B775SV38.USD","LU1116320737.USD","LU2462157665.USD","LU1261432733.SGD","LU2247934214.USD","SGXZ31699556.SGD","F","LU2242650005.HKD","IE0004445239.USD","LU0456855351.SGD","GB00BDT5M118.USD","LU0553294199.USD","LU2430703095.HKD","LU1571399168.USD","BK4533","LU0345770993.USD","LU2125154935.USD","MACW.SI","LU0965508806.USD","LU0417517546.SGD","IE00BK4W5M84.HKD","LU0127658192.USD","SG9999018865.SGD","LU1868837300.USD","LU1366192091.USD","LU2361045086.USD","BK4532","BK4559","BK4550","IE00B7KXQ091.USD","LU0868494708.USD","SG9999015358.SGD","BK4554","LU2552382058.USD","LU0077335932.USD","BK4575","SG9999014898.SGD","LU0109391861.USD"],"gpt_icon":1},{"id":"2492441235","title":"Pharma Stock Roundup: PFE's 2025 Outlook, MRK & ABBV's M&A Deals","url":"https://stock-news.laohu8.com/highlight/detail?id=2492441235","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492441235?lang=en_us&edition=fundamental","pubTime":"2024-12-20 20:27","pubTimestamp":1734697620,"startTime":"0","endTime":"0","summary":"Here's a recap of the week’s most important stories.Pfizer announced encouraging guidance for 2025. In 2025, Pfizer expects to record total revenues between $61.0 billion and $64.0 billion. On an operational basis, revenues in 2025 are expected to rise in a range of approximately flat to 5% from the midpoint of 2024 guidance, excluding the impact of approximately $1.2 billion of non-recurring revenues for Paxlovid.Adjusted earnings are expected in the range of $2.80-$3.00, representing expected operational growth  in the range of 10%-18% year over year from the midpoint of the 2024 guidance, excluding the impact of certain non-recurring items.Merck announced that it is in-licensing exclusive global rights to develop, manufacture and commercializea preclinical GLP-1 receptor agonist, HS-10535, from Chinese biotech Hansoh Pharma. For the exclusive deal, Merck will make an upfront payment of $112 million to Hansoh Pharma, with the latter also being entitled to receive up to $1.9 billion i","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/cJ7Tfg7ljIEMGiDFsviYYw--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/afe95824683969079aeba27c8210bd37","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/cJ7Tfg7ljIEMGiDFsviYYw--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/afe95824683969079aeba27c8210bd37"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/pharma-stock-roundup-pfes-2025-122700744.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE00BLSP4452.SGD","CHMP","LU2089284900.SGD","TEVA","IE00BVYPNV92.GBP","LU0266013472.USD","IE000M9KFDE8.USD","IE00B2B36J28.USD","LU1496350171.SGD","LU0965509010.AUD","LU2237443382.USD","BK4584","LU0006306889.USD","LU0553294199.USD","LU1093756325.SGD","SNY","CD","LU0820561909.HKD","ABBV","IE00BN8TJ469.HKD","LU0029864427.USD","LU2087621335.USD","PFE","LU0321505439.SGD","LU0256863902.USD","MRK","LU2112291526.USD","IE00B19Z3581.USD","BK4585","IE00BVYPNW00.USD","IE00BSNM7G36.USD","LU0795875086.SGD","LU0208291251.USD","IE00BJJMRZ35.SGD","LU0265550359.USD","LU2361045086.USD","LU0943347566.SGD","LU0985481810.HKD","IE00B42XCP33.USD","LU0965509101.SGD","BK4550","LU0708994859.HKD","IE0004445239.USD","SG9999015945.SGD","LU1496350502.SGD","BK4557","IBD","LU0738911758.USD","LU1732800096.USD","LU2361044865.SGD"],"gpt_icon":1},{"id":"2492490717","title":"Sanofi to acquire rights to develop, commercialize aficamten from Corxel","url":"https://stock-news.laohu8.com/highlight/detail?id=2492490717","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492490717?lang=en_us&edition=fundamental","pubTime":"2024-12-20 18:15","pubTimestamp":1734689736,"startTime":"0","endTime":"0","summary":"Cytokinetics (CYTK) announced that Sanofi (SNY) will acquire exclusive rights to develop and commercialize aficamten from Corxel Pharmaceuticals fo...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/sanofi-to-acquire-rights-to-develop-commercialize-aficamten-from-corxel?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/sanofi-to-acquire-rights-to-develop-commercialize-aficamten-from-corxel?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SNYNF","SNY","BK4588","BK4139","CYTK","BK4007","IE00BFXG1179.USD","BK4585","BK4505"],"gpt_icon":0},{"id":"2492499391","title":"Cytokinetics Says Sanofi Acquiring Rights for Aficamten in Greater China","url":"https://stock-news.laohu8.com/highlight/detail?id=2492499391","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492499391?lang=en_us&edition=fundamental","pubTime":"2024-12-20 16:58","pubTimestamp":1734685096,"startTime":"0","endTime":"0","summary":"Cytokinetics (CYTK) said Friday that Sanofi (SNY) will acquire exclusive rights to develop and commercialize aficamten in Greater China to treat obstructive and non-obstructive hypertrophic cardiomyop","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4588","BK4007","SNY","BK4139","BK4585","CYTK","SNYNF","BK4505","IE00BFXG1179.USD"],"gpt_icon":0},{"id":"2492133357","title":"European Equities Traded in the US as American Depositary Rise in Wednesday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2492133357","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492133357?lang=en_us&edition=fundamental","pubTime":"2024-12-19 00:12","pubTimestamp":1734538373,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were trending higher late Wednesday morning, rising 0.18% to 1,338.75 on the S&P Europe Select ADR Index.From continental Europe, the","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4117","BK4139","LU0109394709.USD","BK4505","BK7142","EDAP","BK4532","BK4585","SAN.AU","LU0889565916.HKD","LU2236285917.USD","GNFT","AFG","TCBP","BK4107","IE00BFXG1179.USD","BK4082","AUTL","LU2456880835.USD","BK4132","TRIB","LU2462157665.USD","EVAX","BK4007","LU2417539215.USD","BK4588","BK4521","LU0320765992.SGD","MREO","DBVT","PHG","SAN","BBVA","LU1829250122.USD","BK4568","SNY","AZN","VOD","BCYC","BK4207"],"gpt_icon":0},{"id":"2492136961","title":"Merck's BLA for RSV Antibody Clesrovimab Gets FDA Acceptance","url":"https://stock-news.laohu8.com/highlight/detail?id=2492136961","media":"Zacks","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492136961?lang=en_us&edition=fundamental","pubTime":"2024-12-18 23:00","pubTimestamp":1734534000,"startTime":"0","endTime":"0","summary":"Merck MRK announced that the FDA has accepted the biologics license application  for its investigational prophylactic long-acting monoclonal antibody, clesrovimab , designed to protect infants from respiratory syncytial virus  disease entering their first RSV season.With the FDA accepting the BLA for review, a decision from the regulatory body is expected on June 10, 2025.Clesrovimab is likely to be available by July 2025 in the United States.If approved, clesrovimab can help address the burden of RSV disease in time for the 2025-26 RSV season.Year to date, shares of Merck have declined 8.3% against the industry’s rise of 5.3%.In the first nine months of 2024, Beyfortus recorded sales worth 845 million. Beyfortus sales benefited from early deliveries in the United States and launch in countries like Canada, France, Germany, Spain, Portugal, Belgium and Ireland.In the first nine months of 2024, Arexvy generated 432 million in sales.Arexvy was approved for high-risk adults aged 50-59 yea","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/sWuU5JHrorQjYnKhObHttQ--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/1b28b8f55ab25205feceb1a2771a2b3a","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/sWuU5JHrorQjYnKhObHttQ--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/1b28b8f55ab25205feceb1a2771a2b3a"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/mercks-bla-rsv-antibody-clesrovimab-150000037.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU2361044865.SGD","LU2361044949.HKD","IE00BBT3K403.USD","SG9999014575.USD","SG9999015341.SGD","LU1974910355.USD","LU0320765489.SGD","LU1023059063.AUD","LU1066051811.HKD","LU1093756325.SGD","LU1989772840.SGD","LU0265550946.USD","LU1571399168.USD","LU1061106388.HKD","IE00B1BXHZ80.USD","LU2417539215.USD","BK4550","LU0965509101.SGD","MRK","LU1093756168.USD","LU1037948897.HKD","LU2461242641.AUD","BK4007","LU0861579265.USD","PFE","LU0234572021.USD","BK4592","LU1934455194.USD","BK4534","SG9999014559.SGD","LU0006306889.USD","SG9999014567.USD","SGXZ57979304.SGD","LU2462157665.USD","SNY","LU1116320901.HKD","SG9999002224.SGD","BK4599","LU0985481810.HKD","LU2456880835.USD","LU0868494617.USD","LU1066053197.SGD","IE0002141913.USD","LU1894683348.USD","LU0985320562.USD","SG9999015358.SGD","LU1066051498.USD","AZN","IE00B2B36J28.USD","IE00BSNM7G36.USD"],"gpt_icon":1},{"id":"2492824411","title":"SNY, TEVA Stocks Jump on Encouraging Data From IBD Drug Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2492824411","media":"Zacks","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492824411?lang=en_us&edition=fundamental","pubTime":"2024-12-18 21:21","pubTimestamp":1734528060,"startTime":"0","endTime":"0","summary":"Sanofi SNY and partner Teva Pharmaceuticals TEVA announced positive data from the phase IIb RELIEVE UCCD study on their investigational anti-TL1A therapy, duvakitug , for the treatment of Ulcerative Colitis  and Crohn's disease , the two main types of inflammatory bowel disease . The study met its primary endpoints for both diseases.In the UC group, 36.2% of patients who received a low dose of the drug and 47.8% of patients who received a high dose achieved clinical remission compared to 20.45% for placebo.For the CD group, 26.1% of patients who received a low dose and 47.8% of patients who took a high dose achieved endoscopic response compared to 13% in the placebo group.The companies also plan to report detailed results from the RELIEVE UCCD study at a medical meeting next year.Both UC and CD indications are primary forms of IBD, marked by chronic inflammation in the gastrointestinal tract. In recent years, there has been a surge in the prevalence of these disorders due to genetic fa","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/B7EfA6ERTo_QO90H15uyXw--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/9c1d11cd27737fac4805145de6e5eee0","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/B7EfA6ERTo_QO90H15uyXw--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/9c1d11cd27737fac4805145de6e5eee0"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/sny-teva-stocks-jump-encouraging-132100481.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0122379950.USD","SNY","LU0456855351.SGD","LU0158827948.USD","LU0466842654.USD","IE00BFTCPJ56.SGD","LU1914381329.SGD","LU1003077747.HKD","LU0795875086.SGD","BK4568","LU1267930490.SGD","BK4581","LU1066051225.USD","LU0689472784.USD","LU0545039389.USD","IE0002270589.USD","IE0034235303.USD","JNJ","LU0889566641.SGD","SG9999015952.SGD","LU2237443465.HKD","IE00BFXG1179.USD","TEVA","LU0965508806.USD","ABBV","LU1935042991.SGD","IBD","LU0128525929.USD","LU0310800379.SGD","LU1221951046.USD","CD","LU1059921491.USD","LU1496350502.SGD","LU1839511570.USD","LU1032955483.USD","LU0553294199.USD","IE00B19Z3581.USD","SG9999015986.USD","LU1066053197.SGD","LU1057294990.SGD","IE00BJT1NW94.SGD","IE00B4R5TH58.HKD","LU0943347566.SGD","BK4116","BK4557","LU0640476718.USD","IE00BVYPNV92.GBP","IE00B42XCP33.USD","IE0004445239.USD","LU0256863811.USD"],"gpt_icon":0},{"id":"2492183711","title":"Strength Seen in Sanofi (SNY): Can Its 6.7% Jump Turn into More Strength?","url":"https://stock-news.laohu8.com/highlight/detail?id=2492183711","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492183711?lang=en_us&edition=fundamental","pubTime":"2024-12-18 19:33","pubTimestamp":1734521580,"startTime":"0","endTime":"0","summary":"Sanofi SNY shares soared 6.7% in the last trading session to close at $48.94. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the stock's 5.4% loss over the past four weeks.This jump in share price came after management reported positive results from a mid-stage study on its experimental anti-TL1A therapy, duvakitug, in Ulcerative Colitis and Crohn's disease, which are the two main types of inflammatory bowel disease. The study achieved its primary endpoints for both diseases. The drug is being developed in partnership with Teva Pharmaceuticals.This drugmaker is expected to post quarterly earnings of $0.77 per share in its upcoming report, which represents a year-over-year change of -13.5%. Revenues are expected to be $11.08 billion, down 5.8% from the year-ago quarter.For Sanofi, the consensus EPS estimate for the quarter has been revised 14.3% lower over the last 30 days to the current level. And a negative trend in e","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/D0jwpiVBqNpHXbBsDdtXdQ--~B/aD03Mjg7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/f562a9c28bce92a6a1caa5408fb2ac68","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/D0jwpiVBqNpHXbBsDdtXdQ--~B/aD03Mjg7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/f562a9c28bce92a6a1caa5408fb2ac68"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/strength-seen-sanofi-sny-6-113300051.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE0004445239.USD","LU0820561909.HKD","IE0009355771.USD","BK4550","LU1037948897.HKD","LU1244550221.USD","LU2347655156.SGD","LU2237443622.USD","SNY","SG9999015978.USD","LU0661504455.SGD","LU0203347892.USD","BK4585","SG9999011175.SGD","LU0965509283.SGD","LU1244550494.USD","IE0002141913.USD","LU2237443382.USD","LU1291159041.SGD","LU1934455863.HKD","LU2089283258.USD","LU0170899867.USD","LU0965508806.USD","IE00BSNM7G36.USD","LU0882574055.USD","LU1430594728.SGD","LU0234570918.USD","BK4533","LU0211327993.USD","LU0310799852.SGD","LU0689472784.USD","LU1093756168.USD","LU0545039389.USD","LU1585245621.USD","LU2237443549.SGD","LU1839511570.USD","BK4534","LU0203345920.USD","BK4139","LU0820561818.USD","LU0234572021.USD","LU0211328371.USD","IE00B3PB1722.GBP","LU1496350171.SGD","LU0029864427.USD","ABBV","LU1267930573.SGD","LU0738911758.USD","LU1732799900.SGD","LU1983299246.USD"],"gpt_icon":0},{"id":"2492913423","title":"Equity Markets Fall as Fed Meeting Gets Underway","url":"https://stock-news.laohu8.com/highlight/detail?id=2492913423","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492913423?lang=en_us&edition=fundamental","pubTime":"2024-12-18 05:25","pubTimestamp":1734470727,"startTime":"0","endTime":"0","summary":"US benchmark equity indexes closed lower Tuesday as the Federal Reserve kicked off its two-day monetary policy meeting and traders evaluated the latest economic data.The Dow Jones Industrial Average f","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["SDOW","USAW.SI","TEVA","EQR","US3Y.BOND","SH","UDOW","US2Y.BOND",".DJI","USJW.SI","US30Y.BOND","US6M.BOND","BK4504","IVV","SPY","SDS","SNY","ESmain","SPXU","US12M.BOND","TSYW.SI","BK4596","PFE","MNQmain","PFE.AU","VOO","OEF",".SPX",".IXIC","DJX","OEX","US7Y.BOND","NQmain","NVIW.SI","US10Y.BOND","DDM","PSQ","DOG","QID","QLD","SG9999002224.SGD","SG9999013999.USD","TQQQ","UPRO","US5Y.BOND","SQQQ","SSO","DXD","AMTM"],"gpt_icon":1},{"id":"2492444991","title":"Teva and Sanofi (SNY) Jump amid Impressive Drug Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2492444991","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492444991?lang=en_us&edition=fundamental","pubTime":"2024-12-18 03:13","pubTimestamp":1734462834,"startTime":"0","endTime":"0","summary":"Drugmakers Teva Pharmaceutical ($TEVA) and Sanofi ($SNY) announced earlier today that their experimental antibody therapy, duvakitug, showed impres...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/teva-and-sanofi-sny-jump-amid-impressive-drug-results?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/teva-and-sanofi-sny-jump-amid-impressive-drug-results?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4557","IE00BFXG1179.USD","BK4585","BK4566","BK4559","BK4584","BK4588","BK4596","SNY","TEVA","BK4007"],"gpt_icon":0},{"id":"2492999709","title":"Sector Update: Health Care Stocks Mixed Tuesday Afternoon","url":"https://stock-news.laohu8.com/highlight/detail?id=2492999709","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492999709?lang=en_us&edition=fundamental","pubTime":"2024-12-18 02:57","pubTimestamp":1734461860,"startTime":"0","endTime":"0","summary":"Health care stocks were mixed in Tuesday afternoon trading with the NYSE Health Care Index increasing 0.1% and the Health Care Select Sector SPDR Fund  little changed.The iShares Biotechnology ETF  rose 0.6%.In corporate news, Pfizer  shares gained 4.3%. The company projected higher earnings for 2025 and revenue in line with this year's likely results on \"disciplined execution\" and cost cuts.Teva Pharmaceutical Industries  shares surged 26% after the company's co-developed drug duvakitug was found to benefit people with inflammatory bowel disease. Teva's US affiliate and Sanofi  said a phase 2b study on duvakitug met primary endpoints in people with ulcerative colitis and Crohn's disease. Sanofi shares jumped 7.3%.Vaccinex  shares will be delisted from Nasdaq on Wednesday after the company failed to maintain a minimum of $2.5 million in stockholder equity. The stock plunged 62%.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE000M9KFDE8.USD","BK4533","BK4557","BK4584","SG9999003800.SGD","BK4592","LU0289739699.SGD","BK4581","LU0225771236.USD","BK4599","LU1057294990.SGD","BK4559","PFE","TEVA","IE00BLSP4452.SGD","LU1894683348.USD","LU0234572021.USD","SG9999013999.USD","BK4568","XLV","BK7095","LU1023059063.AUD","IE00BLSP4239.USD","LU1066051498.USD","BK4007","SGXZ57979304.SGD","LU0058720904.USD","IE0002270589.USD","BK4596","LU1883839398.USD","LU0868494617.USD","SG9999002224.SGD","BK4588","LU1066053197.SGD","PFE.AU","LU0170899867.USD","SG9999011175.SGD","LU0225284248.USD","IE00B19Z3581.USD","BK4534","IBB","LU0456855351.SGD","SNY","LU0306806265.USD","BK4139","BK4585","VCNX","SG9999001176.USD","IE00BBT3K403.USD","LU0985481810.HKD"],"gpt_icon":1},{"id":"2492998051","title":"Update: Teva, Sanofi Shares Jump as Phase 2B Duvakitug Study Meets Primary Endpoints in Inflammatory Bowel Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2492998051","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492998051?lang=en_us&edition=fundamental","pubTime":"2024-12-18 01:24","pubTimestamp":1734456257,"startTime":"0","endTime":"0","summary":"Teva Pharmaceutical Industries'  US-listed shares jumped 23% in recent Tuesday trading after the company's co-developed drug duvakitug was found to benefit patients with inflammatory bowel disease.Teva's US affiliate Teva Pharmaceuticals and Sanofi  said that a phase 2b study on duvakitug met primary endpoints in patients with ulcerative colitis and Crohn's disease, the most common forms of inflammatory bowel disease.Sanofi's US-listed shares jumped 6.4% after the news.The companies said 47.8% of ulcerative colitis patients treated with high-dose duvakitug achieved clinical remission at week 14 and 47.8% of Crohn's disease patients on high-dose duvakitug achieved endoscopic response.Duvakitug was well tolerated, with adverse event rates similar between treatment and placebo groups, the companies added.Teva and Sanofi said they plan to initiate a phase 3 trial after regulatory discussions. Detailed results of the phase 2b trial are expected to be presented in 2025, they added.Price: 20.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4584","BK4588","SNYNF","BK4007","BK4585","BK4566","IE00BFXG1179.USD","BK4596","BK4559","SNY","TEVA","BK4557"],"gpt_icon":0},{"id":"2492998324","title":"Teva Stock Soars 19% as Game-Changing IBD Drug Duvakitug Crushes Trial Expectations","url":"https://stock-news.laohu8.com/highlight/detail?id=2492998324","media":"GuruFocus.com","labels":["productRelease","dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492998324?lang=en_us&edition=fundamental","pubTime":"2024-12-18 01:00","pubTimestamp":1734454811,"startTime":"0","endTime":"0","summary":"Teva Pharmaceutical  Industries and Sanofi  just dropped a game-changing update for investorstheir star drug duvakitug smashed expectations in Phase 2b trials, delivering clinical remission in nearly half of Crohn's disease patients at high doses. Conducted across the U.S., Europe, and Israel, the trial met its primary endpoints, showing 47.8% remission rates compared to 20.45% on placebo. The market loved it. Teva's stock skyrocketed 19%, while Sanofi saw a tidy 4% bump, and for good reasonthis positions duvakitug to claim a big slice of the $28 billion inflammatory bowel disease  market.GuruFocus has detected 2 Warning Signs with TEVA.Duvakitug isn't just another drug in Teva's pipelineit's the drug. With consistent efficacy across patient groups and no major safety hiccups, this TL1A antibody therapy is now a frontrunner in the fight against ulcerative colitis and Crohn's. Teva's R&D chief, Eric Hughes, didn't hold back, calling the results beyond expectations, while Sanofi's head o","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/9QVg.4cfA8zfWdjG0PUEqQ--~B/aD00MjE7dz00MjE7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/us.finance.gurufocus/eb52526e6c6491907a7e1ebdc6d8f21b","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/9QVg.4cfA8zfWdjG0PUEqQ--~B/aD00MjE7dz00MjE7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/us.finance.gurufocus/eb52526e6c6491907a7e1ebdc6d8f21b"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/teva-stock-soars-19-game-170011719.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE00BBT3K403.USD","LU1037948541.HKD","LU1989772840.SGD","LU1037948897.HKD","LU2461242641.AUD","IE0002141913.USD","LU1066051498.USD","LU0203345920.USD","IE00B2B36J28.USD","MRK","BK4534","BK4566","LU0965509010.AUD","IE00BFTCPJ56.SGD","BK4557","IBD","LU0266013472.USD","LU0265550359.USD","LU1116320737.USD","IE00BJT1NW94.SGD","IE0009355771.USD","BK4007","SG9999014559.SGD","LU1057294990.SGD","LU2361045086.USD","LU0265550946.USD","SG9999015358.SGD","LU1974910355.USD","LU0238689110.USD","BK4588","LU1941712264.USD","LU1983299246.USD","LU2468319806.SGD","IE00BLSP4239.USD","LU0122379950.USD","SNY","LU0211331839.USD","LU1699723380.USD","LU1585245621.USD","LU1934455863.HKD","LU1093756168.USD","LU0234572021.USD","LU0965508806.USD","LU2361044865.SGD","LU0058720904.USD","BK4516","LU0006306889.USD","SG9999001440.SGD","TEVA","LU0985320562.USD"],"gpt_icon":0},{"id":"2492968641","title":"Teva Shares Soar on Early Bowel Disease Drug Data -- Barrons.com","url":"https://stock-news.laohu8.com/highlight/detail?id=2492968641","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492968641?lang=en_us&edition=fundamental","pubTime":"2024-12-17 22:17","pubTimestamp":1734445020,"startTime":"0","endTime":"0","summary":"Shares of drugmaker Teva Pharmaceutical Industries were up more than 20% in premarket trading Tuesday on the back of promising early data on a treatment for two chronic bowel conditions.Teva and its partner Sanofi said that 47.8% of patients with ulcerative colitis who received a high dose of their drug duvakitug experienced clinical remission, compared with 20.5% who received a placebo.The results were similar for patients with Crohn's disease. The companies said that both responses were significant and clinically meaningful.Teva's American depositary receipts were up 20% in premarket trading, while ADRs of Sanofi, the far larger of the two partners, were up 4.1%.Crohn's disease and ulcerative colitis are both chronic inflammatory conditions impacting the colon. While there are a number of medicines on the market to treat the diseases, Teva called duvakitug \"potentially best-in-class\" in a presentation on Tuesday morning.\"These positive results reinforce Teva's ability to develop and ","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4566","BK4584","IE00BFXG1179.USD","BK4557","BK4588","BK4007","TEVA","SNY","BK4559","BK4596"],"gpt_icon":0},{"id":"2492963561","title":"Why Are Teva And Sanofi Stocks Trading Higher On Tuesday?","url":"https://stock-news.laohu8.com/highlight/detail?id=2492963561","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492963561?lang=en_us&edition=fundamental","pubTime":"2024-12-17 22:16","pubTimestamp":1734444992,"startTime":"0","endTime":"0","summary":"On Tuesday, Teva Pharmaceutical Industries Ltd.  and Sanofi SA’s  Phase 2b RELIEVE UCCD study met its primary endpoints in patients with ulcerative colitis  and Crohn’s disease .RELIEVE UCCD investigated duvakitug , a human IgG1-λ2 monoclonal antibody targeting TL1A, for moderate-to-severe inflammatory bowel disease .In the RELIEVE UCCD study, 36.2%  and 47.8%  of patients with ulcerative colitis treated with duvakitug achieved clinical remission compared to 20.45% on placebo, placebo-adjusted rates were 15.7%  and 27.4% , at week 14.Also Read: Amicus Therapeutics Settles Patent Lawsuit Teva Pharmaceuticals Over Generic Version Of Its Rare Genetic Disorder Drug. Overall, the treatment effect was consistent across subgroups.Duvakitug was generally well tolerated in ulcerative colitis and Crohn’s disease, with no safety signal identified.Ulcerative colitis and Crohn’s disease, the two main types of IBD, are chronic inflammatory conditions of the GI tract resulting in symptoms such as abd","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/KjRbkKbKpeJEOpjN7kNeqA--~B/aD01NTM7dz05ODM7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/Benzinga/bb5745124c89d78e3ebe1a750f38aa02","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/KjRbkKbKpeJEOpjN7kNeqA--~B/aD01NTM7dz05ODM7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/Benzinga/bb5745124c89d78e3ebe1a750f38aa02"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/why-teva-sanofi-stocks-trading-141632272.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4557","SNYNF","SNY","BK4588","AE","BK4596","BK4116","CD","BK4007","TEVA","IBD","BK4585","BK4584","BK4566","IE00BFXG1179.USD","BK4559","BK4138"],"gpt_icon":0},{"id":"2492957101","title":"Teva, Sanofi Say Phase 2B Duvakitug Study Meets Primary Endpoints in Inflammatory Bowel Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2492957101","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492957101?lang=en_us&edition=fundamental","pubTime":"2024-12-17 21:43","pubTimestamp":1734442998,"startTime":"0","endTime":"0","summary":"Teva Pharmaceutical Industries'  US affiliate Teva Pharmaceuticals and Sanofi  said Tuesday that a phase 2b study on duvakitug met primary endpoints in patients with ulcerative colitis and Crohn's disease, the most common forms of inflammatory bowel disease.The companies said 47.8% of ulcerative colitis patients treated with high-dose duvakitug achieved clinical remission at week 14 and 47.8% of Crohn's disease patients on high-dose duvakitug achieved endoscopic response.Duvakitug was well tolerated, with adverse event rates similar between treatment and placebo groups, the companies added.Teva and Sanofi said they plan to initiate a phase 3 trial after regulatory discussions. Detailed results of the phase 2b trial are expected to be presented in 2025, they added.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4585","BK4007","BK4559","SNY","BK4588","TEVA","SNYNF","BK4596","BK4557","IE00BFXG1179.USD","BK4584","BK4566"],"gpt_icon":0},{"id":"1163081867","title":"Pre-Bell｜U.S. Futures Dip; Tesla Gains 2%; Nvidia Drops 2%; Palantir Sinks 3%; Quantum Stocks Shine","url":"https://stock-news.laohu8.com/highlight/detail?id=1163081867","media":"Tiger Newspress","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1163081867?lang=en_us&edition=fundamental","pubTime":"2024-12-17 21:43","pubTimestamp":1734442980,"startTime":"0","endTime":"0","summary":"U.S. stock index futures dipped on Tuesday, with rising bond yields adding pressure as traders braced for retail sales data that will provide more clues on the health of consumers ahead of an anticipa","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"3b1e74be79ddbb8b0eefa5ab5c7ba16b","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TSLA","SNY","QMCO","QBTS","NVDA","YMmain","NQmain","NUE","RGTI",".SPX",".DJI","SEDG","RCAT","TEVA","AVGO","PFE","AFRM","NET","ESmain","EVGO","AMTM",".IXIC","PLTR","QUBT"],"gpt_icon":1},{"id":"2492195222","title":"Teva, Sanofi Say IBD Treatment Achieved Higher Remission at Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2492195222","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492195222?lang=en_us&edition=fundamental","pubTime":"2024-12-17 21:30","pubTimestamp":1734442200,"startTime":"0","endTime":"0","summary":"Teva Pharmaceuticals and Sanofi report that the latest trial of their jointly developed treatment for inflammatory bowel disease met its primary endpoints.The companies said Tuesday that patients with ulcerative colitis who were treated with duvakitug achieved a higher rate of clinical remission compared with a placebo group. A group of patients with Crohn's disease who were treated with duvakitug achieved a higher rate of remission than those treated with a placebo.The treatment effect was consistent across subgroups, the companies said.Teva's shares surged 18% to $19.53 in premarket trading. Sanofi's American depositary receipts were up 3.7% at $47.57.Duvakitug was generally well tolerated across both patient groups and showed similar rates of treatment-emergent adverse events.\"I am deeply moved by the potential for duvakitug to help treat and meaningfully improve the quality of life of people living with IBD,\" Hughes said.Teva and Sanofi said in November 2023 that they had closed a ","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BK4585","BK4584","SNY","SNYNF","TEVA","BK4557","BK4566","BK4559","BK4596","IE00BFXG1179.USD","IBD","BK4588"],"gpt_icon":0},{"id":"2492959530","title":"Teva, Sanofi Say Drug to Treat IBD Met Primary Targets","url":"https://stock-news.laohu8.com/highlight/detail?id=2492959530","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492959530?lang=en_us&edition=fundamental","pubTime":"2024-12-17 21:10","pubTimestamp":1734441000,"startTime":"0","endTime":"0","summary":"Teva, Sanofi say drug to treat IBD met primary targetsBy Steven Scheer","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241217:nL8N3NI0PE:1","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Teva, Sanofi Say Drug to Treat IBD Met Primary Targets","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SNY","TEVA"],"gpt_icon":1}],"pageSize":20,"totalPage":10,"pageCount":9,"totalSize":200,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SNY\",params:#limit:5,,,undefined,":[{"date":"2025-05-09","symbol":"SNY","amount":2.212154,"announcedDate":"2025-04-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-05-09","defaultRemindTime":1746797400000,"name":"赛诺菲安万特","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-12","payableDate":"2025-05-09","currency":"USD","dateTimestamp":1746763200000,"payDate":"2025-06-12"},{"market":"US","date":"2025-04-24","symbol":"SNY","fiscalQuarterEnding":"2025/03","expectedEps":0.9,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1745467200000,"reportTimeType":"pre","actualEps":0.94},{"market":"US","date":"2025-01-30","symbol":"SNY","fiscalQuarterEnding":"2024/12","expectedEps":0.71,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1738213200000,"reportTimeType":"pre","actualEps":0.7},{"market":"US","date":"2024-10-25","symbol":"SNY","fiscalQuarterEnding":"2024/09","expectedEps":1.35,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1729828800000,"reportTimeType":"pre","actualEps":1.57},{"date":"2024-09-12","symbol":"SNY","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1726128000000,"name":null,"time":"Pre-Market","dateTimestamp":1726113600000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SNY\",market:\"US\",,,undefined,":[{"executeDate":"2015-05-06","recordDate":"2015-05-08","paymentDate":"2015-06-02","value":1.086507,"currency":"USD"},{"executeDate":"2016-05-05","recordDate":"2016-05-09","paymentDate":"2016-06-01","value":1.124297,"currency":"USD"},{"executeDate":"2017-05-11","recordDate":"2017-05-15","paymentDate":"2017-06-07","value":1.053962,"currency":"USD"},{"executeDate":"2018-05-09","recordDate":"2018-05-10","paymentDate":"2018-06-04","value":1.252612,"currency":"USD"},{"executeDate":"2019-05-07","recordDate":"2019-05-08","paymentDate":"2019-05-31","value":1.739462,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"SNY\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.4286,"buy":0.2857,"hold":0.2857,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.2857,"analysts":7,"updateTime":1742788800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/SNY\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"SNY","date":"2025-04-28","current":18.091389,"percent":0.55892,"low":7.700371,"twenty":10.042807,"median":17.659092,"eighty":24.157724,"high":35.240461,"avg":17.757772,"sd":6.897386,"marketCap":129659412412.11},"quantilePoints":[{"date":"2020-05-01","current":33.287209,"twenty":10.936939,"median":22.288206,"eighty":27.915788,"marketCap":122748871163.92},{"date":"2020-05-08","current":33.429348,"twenty":10.947749,"median":22.313398,"eighty":28.361828,"marketCap":121627238914.58},{"date":"2020-05-15","current":32.595691,"twenty":10.949613,"median":22.330456,"eighty":28.489712,"marketCap":118247569927.49},{"date":"2020-05-22","current":32.461152,"twenty":10.950809,"median":22.368981,"eighty":28.664689,"marketCap":118529173787.58},{"date":"2020-05-29","current":32.711543,"twenty":10.957417,"median":22.45326,"eighty":28.739014,"marketCap":121900047291.83},{"date":"2020-06-05","current":33.320704,"twenty":10.961705,"median":22.504413,"eighty":28.869762,"marketCap":126404479866.46},{"date":"2020-06-12","current":33.26848,"twenty":10.97427,"median":22.552737,"eighty":29.165734,"marketCap":125312894610.63},{"date":"2020-06-19","current":35.174448,"twenty":10.980961,"median":22.560851,"eighty":29.253683,"marketCap":131987852645.25},{"date":"2020-06-26","current":34.045816,"twenty":10.987268,"median":22.616571,"eighty":29.711727,"marketCap":127924643785.45},{"date":"2020-07-02","current":34.367214,"twenty":10.994274,"median":22.648355,"eighty":29.771242,"marketCap":129509727296.23},{"date":"2020-07-10","current":33.233448,"twenty":10.9995,"median":22.663506,"eighty":32.384166,"marketCap":126030678803.03},{"date":"2020-07-17","current":34.840553,"twenty":11.002375,"median":22.680357,"eighty":32.642032,"marketCap":133469182626.29},{"date":"2020-07-24","current":33.192336,"twenty":11.004309,"median":22.714228,"eighty":32.855777,"marketCap":129403011819.03},{"date":"2020-07-31","current":10.079688,"twenty":10.9995,"median":22.705861,"eighty":32.972702,"marketCap":131609513547.85},{"date":"2020-08-07","current":9.946507,"twenty":10.971294,"median":22.66842,"eighty":32.855777,"marketCap":129396034746.58},{"date":"2020-08-14","current":9.727952,"twenty":10.948867,"median":22.658549,"eighty":32.749663,"marketCap":127031956635.12},{"date":"2020-08-21","current":9.828123,"twenty":10.929747,"median":22.644775,"eighty":32.720989,"marketCap":127780651499.59},{"date":"2020-08-28","current":9.679005,"twenty":10.883242,"median":22.578254,"eighty":32.71485,"marketCap":127069323852.74},{"date":"2020-09-04","current":9.512813,"twenty":10.85502,"median":22.559456,"eighty":32.642032,"marketCap":123841606541.64},{"date":"2020-09-11","current":9.96472,"twenty":10.823199,"median":22.547298,"eighty":32.561309,"marketCap":130185382800.66},{"date":"2020-09-18","current":10.067167,"twenty":10.684765,"median":22.493564,"eighty":32.490302,"marketCap":131820291420.1},{"date":"2020-09-25","current":9.858857,"twenty":10.595525,"median":22.444418,"eighty":32.458162,"marketCap":126422921729.99},{"date":"2020-10-02","current":9.798527,"twenty":10.526117,"median":22.342652,"eighty":32.407337,"marketCap":126679565248.92},{"date":"2020-10-09","current":9.824708,"twenty":10.410161,"median":22.324584,"eighty":32.285505,"marketCap":128128683268.34},{"date":"2020-10-16","current":9.793052,"twenty":10.315413,"median":22.302943,"eighty":31.257628,"marketCap":126623612278.58},{"date":"2020-10-23","current":9.441308,"twenty":10.238589,"median":22.261435,"eighty":29.811136,"marketCap":123347203619.79},{"date":"2020-10-30","current":8.661295,"twenty":10.199611,"median":22.234806,"eighty":29.773341,"marketCap":113280166110.01},{"date":"2020-11-06","current":9.327376,"twenty":10.132097,"median":22.205679,"eighty":29.767042,"marketCap":124442629581.55},{"date":"2020-11-13","current":9.605003,"twenty":10.089923,"median":22.112471,"eighty":29.762798,"marketCap":127479835927.15},{"date":"2020-11-20","current":9.6106,"twenty":10.079688,"median":22.081393,"eighty":29.73408,"marketCap":127917182157.26},{"date":"2020-11-27","current":9.538955,"twenty":10.057978,"median":22.005256,"eighty":29.655002,"marketCap":127995801275.71},{"date":"2020-12-04","current":9.358721,"twenty":10.040076,"median":21.945075,"eighty":29.437865,"marketCap":127467141893.2},{"date":"2020-12-11","current":8.790033,"twenty":10.022546,"median":21.91943,"eighty":29.296005,"marketCap":119489512407.95},{"date":"2020-12-18","current":8.844887,"twenty":9.993694,"median":21.901999,"eighty":29.279125,"marketCap":121396802063.1},{"date":"2020-12-24","current":8.769883,"twenty":9.976103,"median":21.881466,"eighty":29.245202,"marketCap":119941986349.01},{"date":"2020-12-31","current":8.810183,"twenty":9.961936,"median":21.873052,"eighty":29.24273,"marketCap":120950078152.91},{"date":"2021-01-08","current":8.820259,"twenty":9.95106,"median":21.862976,"eighty":29.210969,"marketCap":121221849881.21},{"date":"2021-01-15","current":9.126992,"twenty":9.936588,"median":21.828735,"eighty":29.197581,"marketCap":123845036018.62},{"date":"2021-01-22","current":9.119156,"twenty":9.919292,"median":21.813001,"eighty":29.173346,"marketCap":124582207014},{"date":"2021-01-29","current":8.636715,"twenty":9.906894,"median":21.809329,"eighty":29.059102,"marketCap":117661873131.83},{"date":"2021-02-05","current":8.176599,"twenty":9.88162,"median":21.779975,"eighty":28.982923,"marketCap":120922774999.4},{"date":"2021-02-12","current":7.987538,"twenty":9.856239,"median":21.763827,"eighty":28.950951,"marketCap":119014418424.43},{"date":"2021-02-19","current":7.870014,"twenty":9.848372,"median":21.763595,"eighty":28.901957,"marketCap":117391358460.33},{"date":"2021-02-26","current":7.746359,"twenty":9.840411,"median":21.746147,"eighty":28.832667,"marketCap":115225330598.91},{"date":"2021-03-05","current":7.860937,"twenty":9.827943,"median":21.729717,"eighty":28.787173,"marketCap":115132662522.04},{"date":"2021-03-12","current":8.118972,"twenty":9.808685,"median":21.685029,"eighty":28.757776,"marketCap":119210132761.26},{"date":"2021-03-19","current":8.502978,"twenty":9.798186,"median":21.612115,"eighty":28.742096,"marketCap":124417528040.94},{"date":"2021-03-26","current":8.489771,"twenty":9.792219,"median":21.598158,"eighty":28.727957,"marketCap":123096173961.55},{"date":"2021-04-01","current":8.553964,"twenty":9.788159,"median":21.54258,"eighty":28.711437,"marketCap":123735063715.73},{"date":"2021-04-09","current":8.641332,"twenty":9.782356,"median":21.526019,"eighty":28.694903,"marketCap":126246626546.64},{"date":"2021-04-16","current":8.636253,"twenty":9.769654,"median":21.512492,"eighty":28.66049,"marketCap":127185060180.88},{"date":"2021-04-23","current":8.669778,"twenty":9.761091,"median":21.479045,"eighty":28.625112,"marketCap":128556561372.57},{"date":"2021-04-30","current":8.936356,"twenty":9.755206,"median":21.457669,"eighty":28.539275,"marketCap":131116008424.15},{"date":"2021-05-07","current":8.761308,"twenty":9.751942,"median":21.433287,"eighty":28.492512,"marketCap":129875631253.04},{"date":"2021-05-14","current":8.892563,"twenty":9.741584,"median":21.426198,"eighty":28.475014,"marketCap":131645337996.12},{"date":"2021-05-21","current":9.047404,"twenty":9.729833,"median":21.41999,"eighty":28.415141,"marketCap":134492606805.61},{"date":"2021-05-28","current":9.019717,"twenty":9.710422,"median":21.40835,"eighty":28.40452,"marketCap":134081034734.92},{"date":"2021-06-04","current":8.826935,"twenty":9.707463,"median":21.392314,"eighty":28.379325,"marketCap":130991765454.43},{"date":"2021-06-11","current":9.116284,"twenty":9.694395,"median":21.363939,"eighty":28.361828,"marketCap":134500207706.54},{"date":"2021-06-18","current":9.021943,"twenty":9.679005,"median":21.290156,"eighty":28.230746,"marketCap":130457184786.01},{"date":"2021-06-25","current":9.04963,"twenty":9.672117,"median":21.229467,"eighty":28.073267,"marketCap":131826509965.36},{"date":"2021-07-02","current":9.013739,"twenty":9.660792,"median":21.196129,"eighty":27.996278,"marketCap":130199639608.01},{"date":"2021-07-09","current":8.944008,"twenty":9.658829,"median":21.16444,"eighty":27.931886,"marketCap":129422313900.82},{"date":"2021-07-16","current":9.010663,"twenty":9.638085,"median":21.140332,"eighty":27.848598,"marketCap":129770992211.6},{"date":"2021-07-23","current":9.031172,"twenty":9.62122,"median":21.117164,"eighty":27.80391,"marketCap":129576758627.22},{"date":"2021-07-30","current":18.87536,"twenty":9.610467,"median":21.085355,"eighty":27.796937,"marketCap":129351074870.7},{"date":"2021-08-06","current":18.73975,"twenty":9.613461,"median":21.013453,"eighty":27.749237,"marketCap":127349176618.04},{"date":"2021-08-13","current":19.000477,"twenty":9.62122,"median":20.964049,"eighty":27.709316,"marketCap":129532398703.09},{"date":"2021-08-20","current":19.713131,"twenty":9.626758,"median":20.922915,"eighty":27.702194,"marketCap":133040601577.1},{"date":"2021-08-27","current":19.159086,"twenty":9.631579,"median":20.849323,"eighty":27.682689,"marketCap":130505881690.84},{"date":"2021-09-03","current":19.087386,"twenty":9.636484,"median":20.812207,"eighty":27.640133,"marketCap":131037228600.12},{"date":"2021-09-10","current":17.788527,"twenty":9.637931,"median":20.810313,"eighty":27.621196,"marketCap":121557039339.96},{"date":"2021-09-17","current":17.718998,"twenty":9.644258,"median":20.781658,"eighty":27.597623,"marketCap":120158061709.12},{"date":"2021-09-24","current":17.821119,"twenty":9.653374,"median":20.756596,"eighty":27.571856,"marketCap":120553399377.05},{"date":"2021-10-01","current":17.949313,"twenty":9.657986,"median":20.686673,"eighty":27.533829,"marketCap":120210038226.29},{"date":"2021-10-08","current":18.316512,"twenty":9.65882,"median":20.60166,"eighty":27.49647,"marketCap":122456300914.25},{"date":"2021-10-15","current":18.21668,"twenty":9.659965,"median":20.367209,"eighty":27.481537,"marketCap":122085570969.84},{"date":"2021-10-22","current":18.492625,"twenty":9.660762,"median":19.534967,"eighty":27.418547,"marketCap":124266480579.27},{"date":"2021-10-29","current":17.57188,"twenty":9.660792,"median":19.400258,"eighty":27.363912,"marketCap":125449567069.84},{"date":"2021-11-05","current":17.984594,"twenty":9.662246,"median":19.19059,"eighty":27.343794,"marketCap":128307008370.7},{"date":"2021-11-12","current":18.139856,"twenty":9.664147,"median":19.148222,"eighty":27.315537,"marketCap":128214619445.91},{"date":"2021-11-19","current":18.074795,"twenty":9.669177,"median":19.129754,"eighty":27.3008,"marketCap":126337351612.14},{"date":"2021-11-26","current":17.283895,"twenty":9.672117,"median":19.062399,"eighty":27.290992,"marketCap":120754520924.52},{"date":"2021-12-03","current":17.031784,"twenty":9.672185,"median":18.974404,"eighty":27.274231,"marketCap":118697631154.76},{"date":"2021-12-10","current":17.593219,"twenty":9.673996,"median":18.883829,"eighty":27.261649,"marketCap":122887806332.16},{"date":"2021-12-17","current":17.666414,"twenty":9.676585,"median":18.822313,"eighty":27.226753,"marketCap":122981663791.86},{"date":"2021-12-23","current":17.924629,"twenty":9.677102,"median":18.797147,"eighty":27.187184,"marketCap":125231028798.23},{"date":"2021-12-31","current":18.010023,"twenty":9.680432,"median":18.68789,"eighty":27.152672,"marketCap":126457276638.23},{"date":"2022-01-07","current":18.01409,"twenty":9.687791,"median":18.583882,"eighty":27.099359,"marketCap":126127227506.24},{"date":"2022-01-14","current":18.425049,"twenty":9.694395,"median":18.458837,"eighty":27.042911,"marketCap":129932901404.91},{"date":"2022-01-21","current":18.490113,"twenty":9.694395,"median":18.493429,"eighty":27.028616,"marketCap":129474826588.41},{"date":"2022-01-28","current":19.165142,"twenty":9.694395,"median":18.494232,"eighty":27.028595,"marketCap":132074546389.11},{"date":"2022-02-04","current":18.213402,"twenty":9.69608,"median":18.572578,"eighty":27.025402,"marketCap":129696764676.74},{"date":"2022-02-11","current":18.927495,"twenty":9.697119,"median":18.616113,"eighty":27.010232,"marketCap":134335997389.37},{"date":"2022-02-18","current":18.766118,"twenty":9.697119,"median":18.604323,"eighty":27.010232,"marketCap":132345369395.97},{"date":"2022-02-25","current":18.833821,"twenty":9.697119,"median":18.575534,"eighty":27.010232,"marketCap":132044689275.57},{"date":"2022-03-04","current":17.617959,"twenty":9.697119,"median":18.491369,"eighty":27.010232,"marketCap":119664437682.82},{"date":"2022-03-11","current":18.783661,"twenty":9.697119,"median":18.43883,"eighty":27.010232,"marketCap":127973204254.43},{"date":"2022-03-18","current":18.717451,"twenty":9.697119,"median":18.43883,"eighty":27.010232,"marketCap":128848117335.18},{"date":"2022-03-25","current":18.683343,"twenty":9.697119,"median":18.43883,"eighty":27.010232,"marketCap":127751282161.3},{"date":"2022-04-01","current":18.889374,"twenty":9.697119,"median":18.43883,"eighty":27.010232,"marketCap":129744565958.06},{"date":"2022-04-08","current":20.960102,"twenty":9.697119,"median":18.43883,"eighty":27.010232,"marketCap":141869390625.41},{"date":"2022-04-14","current":20.695242,"twenty":9.697119,"median":18.43883,"eighty":27.010232,"marketCap":139183497682.91},{"date":"2022-04-22","current":20.346108,"twenty":9.697119,"median":18.43883,"eighty":27.010232,"marketCap":136481434838.85},{"date":"2022-04-29","current":18.952765,"twenty":9.697119,"median":18.43883,"eighty":27.010232,"marketCap":133142723720.1},{"date":"2022-05-06","current":18.179144,"twenty":9.697119,"median":18.493429,"eighty":27.010232,"marketCap":128384549744.68},{"date":"2022-05-13","current":18.692394,"twenty":9.697119,"median":18.527753,"eighty":27.010232,"marketCap":129700736023.73},{"date":"2022-05-20","current":19.16256,"twenty":9.697119,"median":18.604323,"eighty":27.010232,"marketCap":134758546837.22},{"date":"2022-05-27","current":19.177546,"twenty":9.697119,"median":18.665261,"eighty":27.010232,"marketCap":136958987699.81},{"date":"2022-06-03","current":18.744225,"twenty":9.697119,"median":18.681313,"eighty":27.010232,"marketCap":133921762001.07},{"date":"2022-06-10","current":18.146643,"twenty":9.697119,"median":18.685349,"eighty":27.010232,"marketCap":127291929717.98},{"date":"2022-06-17","current":17.640852,"twenty":9.697119,"median":18.685349,"eighty":27.010232,"marketCap":123044805550.91},{"date":"2022-06-24","current":18.83789,"twenty":9.696859,"median":18.692394,"eighty":27.014025,"marketCap":132461365342.83},{"date":"2022-07-01","current":18.293193,"twenty":9.696859,"median":18.693435,"eighty":27.014025,"marketCap":126838383992.09},{"date":"2022-07-08","current":18.63272,"twenty":9.696859,"median":18.693435,"eighty":27.014025,"marketCap":126418025181.68},{"date":"2022-07-15","current":18.795918,"twenty":9.696859,"median":18.717451,"eighty":27.014025,"marketCap":126431471445.01},{"date":"2022-07-22","current":18.263208,"twenty":9.696859,"median":18.719457,"eighty":27.014025,"marketCap":124455681540.58},{"date":"2022-07-29","current":18.321107,"twenty":9.696859,"median":18.719457,"eighty":27.014025,"marketCap":124140260314.16},{"date":"2022-08-05","current":18.377647,"twenty":9.696859,"median":18.719457,"eighty":27.014025,"marketCap":123992191551.9},{"date":"2022-08-12","current":16.132936,"twenty":9.696859,"median":18.719457,"eighty":27.014025,"marketCap":109885258896.75},{"date":"2022-08-19","current":15.415581,"twenty":9.696859,"median":18.719457,"eighty":27.014025,"marketCap":102816971778.11},{"date":"2022-08-26","current":15.459,"twenty":9.696859,"median":18.719457,"eighty":27.014025,"marketCap":102642813930.03},{"date":"2022-09-02","current":15.37405,"twenty":9.696859,"median":18.719457,"eighty":27.014025,"marketCap":102457677511.04},{"date":"2022-09-09","current":15.328743,"twenty":9.696859,"median":18.719457,"eighty":27.014025,"marketCap":102237792167.67},{"date":"2022-09-16","current":15.453336,"twenty":9.696859,"median":18.719457,"eighty":27.014025,"marketCap":102882856127.48},{"date":"2022-09-23","current":14.877565,"twenty":9.696859,"median":18.719457,"eighty":27.014025,"marketCap":96093011237.72},{"date":"2022-09-30","current":14.800166,"twenty":9.696859,"median":18.719457,"eighty":27.014025,"marketCap":96408611153.17},{"date":"2022-10-07","current":15.132414,"twenty":9.696859,"median":18.719457,"eighty":27.014025,"marketCap":98274151179.98},{"date":"2022-10-14","current":15.398591,"twenty":9.696859,"median":18.719457,"eighty":27.014025,"marketCap":99690906745.93},{"date":"2022-10-21","current":15.398591,"twenty":9.696859,"median":18.719457,"eighty":27.014025,"marketCap":100326441165.16},{"date":"2022-10-28","current":16.846401,"twenty":9.696859,"median":18.719457,"eighty":27.014025,"marketCap":107356651323.46},{"date":"2022-11-04","current":17.17473,"twenty":9.696859,"median":18.719457,"eighty":27.014025,"marketCap":109112652999.6},{"date":"2022-11-11","current":16.109615,"twenty":9.696859,"median":18.719457,"eighty":27.014025,"marketCap":106637600025.82},{"date":"2022-11-18","current":16.83559,"twenty":9.696859,"median":18.719457,"eighty":27.014025,"marketCap":111812739546.11},{"date":"2022-11-25","current":17.129097,"twenty":9.696859,"median":18.719457,"eighty":27.014025,"marketCap":114152420880.73},{"date":"2022-12-02","current":16.782758,"twenty":9.696859,"median":18.719457,"eighty":27.014025,"marketCap":112782528627.45},{"date":"2022-12-09","current":17.361946,"twenty":9.696859,"median":18.719457,"eighty":27.014025,"marketCap":117264953276.43},{"date":"2022-12-16","current":17.144751,"twenty":9.696859,"median":18.719457,"eighty":27.014025,"marketCap":116510134592.3},{"date":"2022-12-23","current":17.802208,"twenty":9.696859,"median":18.719457,"eighty":27.014025,"marketCap":121183588329.26},{"date":"2022-12-30","current":17.579142,"twenty":9.696859,"median":18.719457,"eighty":27.014025,"marketCap":120406882967.83},{"date":"2023-01-06","current":17.829602,"twenty":9.696859,"median":18.719457,"eighty":27.014025,"marketCap":121279894677.35},{"date":"2023-01-13","current":17.841342,"twenty":9.696859,"median":18.719457,"eighty":27.014025,"marketCap":123710007946.55},{"date":"2023-01-20","current":17.659092,"twenty":9.696859,"median":18.719457,"eighty":27.014025,"marketCap":122645342505.42},{"date":"2023-01-27","current":17.429425,"twenty":9.703429,"median":18.719457,"eighty":27.014025,"marketCap":121260511615.28},{"date":"2023-02-03","current":12.687149,"twenty":9.709538,"median":18.719457,"eighty":27.014025,"marketCap":115251355422.68},{"date":"2023-02-10","current":13.217643,"twenty":9.726396,"median":18.719457,"eighty":27.014025,"marketCap":118159855219.99},{"date":"2023-02-17","current":13.277249,"twenty":9.741642,"median":18.719457,"eighty":27.014025,"marketCap":118515515804.01},{"date":"2023-02-24","current":13.411211,"twenty":9.752083,"median":18.719457,"eighty":27.014025,"marketCap":118448244308.93},{"date":"2023-03-03","current":13.302322,"twenty":9.756767,"median":18.719457,"eighty":27.014025,"marketCap":118034490740.94},{"date":"2023-03-10","current":13.357512,"twenty":9.764714,"median":18.719457,"eighty":27.014025,"marketCap":119257397037.12},{"date":"2023-03-17","current":13.394803,"twenty":9.773462,"median":18.719457,"eighty":27.014025,"marketCap":119526591543.55},{"date":"2023-03-24","current":14.48369,"twenty":9.785178,"median":18.719457,"eighty":27.014025,"marketCap":130424881067.13},{"date":"2023-03-31","current":14.952061,"twenty":9.790694,"median":18.718645,"eighty":27.010232,"marketCap":135988374469.8},{"date":"2023-04-06","current":15.280218,"twenty":9.798413,"median":18.718645,"eighty":27.010232,"marketCap":139686260171.45},{"date":"2023-04-14","current":15.221476,"twenty":9.80991,"median":18.730688,"eighty":27.025402,"marketCap":140825574178.82},{"date":"2023-04-19","current":15.209543,"twenty":9.82744,"median":18.731112,"eighty":27.026041,"marketCap":139558349488.11},{"date":"2023-04-27","current":15.21474,"twenty":9.850092,"median":18.73173,"eighty":27.027318,"marketCap":140140612943.9},{"date":"2023-05-05","current":15.175888,"twenty":9.902113,"median":18.731826,"eighty":27.028595,"marketCap":139552044885.56},{"date":"2023-05-12","current":14.838181,"twenty":9.939677,"median":18.731826,"eighty":27.028595,"marketCap":135403671391.13},{"date":"2023-05-19","current":15.184854,"twenty":9.959028,"median":18.731826,"eighty":27.028595,"marketCap":136642429723.27},{"date":"2023-05-26","current":14.853124,"twenty":9.978835,"median":18.733652,"eighty":27.028599,"marketCap":133126940240.24},{"date":"2023-06-02","current":14.192653,"twenty":10.040758,"median":18.733652,"eighty":27.028599,"marketCap":127343787455.44},{"date":"2023-06-09","current":14.256612,"twenty":10.09699,"median":18.733652,"eighty":27.028599,"marketCap":128372490395.43},{"date":"2023-06-16","current":14.295467,"twenty":10.208772,"median":18.72486,"eighty":27.028599,"marketCap":130508209942.1},{"date":"2023-06-23","current":14.734821,"twenty":10.181908,"median":18.697387,"eighty":27.028603,"marketCap":134961533039.24},{"date":"2023-06-30","current":14.675045,"twenty":10.181908,"median":18.683343,"eighty":27.028603,"marketCap":133521342889.49},{"date":"2023-07-07","current":14.039924,"twenty":10.181908,"median":18.651241,"eighty":27.028603,"marketCap":127451273212.04},{"date":"2023-07-14","current":14.002564,"twenty":10.181908,"median":18.628706,"eighty":27.028603,"marketCap":130982117535.26},{"date":"2023-07-21","current":14.736316,"twenty":10.181908,"median":18.609955,"eighty":27.028603,"marketCap":137261916493.54},{"date":"2023-07-28","current":14.230057,"twenty":10.155044,"median":18.575133,"eighty":27.028608,"marketCap":130696325708.32},{"date":"2023-08-04","current":13.64955,"twenty":10.155044,"median":18.53333,"eighty":27.028608,"marketCap":128783719369.32},{"date":"2023-08-11","current":14.107345,"twenty":10.155044,"median":18.465688,"eighty":27.028608,"marketCap":133909438393.92},{"date":"2023-08-18","current":14.257236,"twenty":10.155044,"median":18.417461,"eighty":27.028608,"marketCap":133639295738.06},{"date":"2023-08-25","current":14.360528,"twenty":10.155044,"median":18.371061,"eighty":27.028608,"marketCap":134024340566.45},{"date":"2023-09-01","current":14.34598,"twenty":10.155044,"median":18.34457,"eighty":27.028608,"marketCap":134077344689.8},{"date":"2023-09-08","current":14.597664,"twenty":10.155044,"median":18.325923,"eighty":27.028608,"marketCap":134604678073.84},{"date":"2023-09-15","current":14.95555,"twenty":10.155044,"median":18.296091,"eighty":27.016307,"marketCap":137463437822.93},{"date":"2023-09-22","current":14.853801,"twenty":10.12818,"median":18.276078,"eighty":27.020855,"marketCap":136484543397.31},{"date":"2023-09-29","current":14.763602,"twenty":10.12818,"median":18.246983,"eighty":26.983029,"marketCap":134423031209.85},{"date":"2023-10-06","current":14.868349,"twenty":10.12818,"median":18.218159,"eighty":26.938973,"marketCap":134892153493.37},{"date":"2023-10-13","current":15.040019,"twenty":10.12818,"median":18.16832,"eighty":26.598464,"marketCap":136737545848.28},{"date":"2023-10-20","current":14.380784,"twenty":10.12818,"median":18.144978,"eighty":26.402781,"marketCap":131062102932.84},{"date":"2023-10-27","current":11.85036,"twenty":10.092665,"median":18.111628,"eighty":26.025777,"marketCap":107534279335.51},{"date":"2023-11-03","current":11.80423,"twenty":10.092665,"median":18.07332,"eighty":25.817137,"marketCap":113606320100.85},{"date":"2023-11-10","current":11.775378,"twenty":10.092665,"median":18.059836,"eighty":25.817137,"marketCap":114360557197.64},{"date":"2023-11-17","current":11.879108,"twenty":10.092665,"median":18.023837,"eighty":25.817137,"marketCap":116984566837.93},{"date":"2023-11-24","current":11.946878,"twenty":10.092665,"median":18.009006,"eighty":25.817137,"marketCap":118113843833.15},{"date":"2023-12-01","current":11.863894,"twenty":10.092665,"median":17.972228,"eighty":25.817137,"marketCap":117306211282.58},{"date":"2023-12-08","current":11.912301,"twenty":10.09699,"median":17.952065,"eighty":25.812238,"marketCap":116514105188.26},{"date":"2023-12-15","current":12.129442,"twenty":10.09699,"median":17.934507,"eighty":25.812238,"marketCap":120907663627.27},{"date":"2023-12-22","current":12.356264,"twenty":10.09699,"median":17.886813,"eighty":25.812238,"marketCap":123141571763.22},{"date":"2023-12-29","current":12.414352,"twenty":10.092665,"median":17.852857,"eighty":25.817137,"marketCap":124666059594.59},{"date":"2024-01-05","current":12.928851,"twenty":10.088339,"median":17.827036,"eighty":25.822036,"marketCap":128452561703.01},{"date":"2024-01-12","current":13.228975,"twenty":10.088339,"median":17.806558,"eighty":25.822036,"marketCap":131304891825.05},{"date":"2024-01-19","current":13.006481,"twenty":10.084014,"median":17.776767,"eighty":25.826935,"marketCap":128114681751.41},{"date":"2024-01-26","current":12.735372,"twenty":10.088339,"median":17.745072,"eighty":25.822036,"marketCap":125131555256.31},{"date":"2024-02-02","current":20.334039,"twenty":10.088339,"median":17.71521,"eighty":25.822036,"marketCap":119118906599.05},{"date":"2024-02-09","current":20.085581,"twenty":10.088339,"median":17.71521,"eighty":25.822036,"marketCap":116751493787.94},{"date":"2024-02-16","current":20.076293,"twenty":10.088339,"median":17.71521,"eighty":25.822036,"marketCap":116634730314.15},{"date":"2024-02-23","current":20.830953,"twenty":10.088339,"median":17.71521,"eighty":25.822036,"marketCap":121673497945.92},{"date":"2024-03-01","current":20.187328,"twenty":10.092665,"median":17.717104,"eighty":25.817137,"marketCap":117837605321.59},{"date":"2024-03-08","current":20.275189,"twenty":10.092665,"median":17.717104,"eighty":25.817137,"marketCap":119656853104.92},{"date":"2024-03-15","current":20.393108,"twenty":10.092665,"median":17.717104,"eighty":25.817137,"marketCap":119946394721.71},{"date":"2024-03-22","current":20.497155,"twenty":10.092665,"median":17.717104,"eighty":25.817137,"marketCap":120191807946.57},{"date":"2024-03-28","current":21.03126,"twenty":10.092665,"median":17.717104,"eighty":25.817137,"marketCap":122670991700.15},{"date":"2024-04-05","current":20.194264,"twenty":10.088339,"median":17.71521,"eighty":25.822036,"marketCap":118454296559.85},{"date":"2024-04-12","current":19.993107,"twenty":10.088339,"median":17.71521,"eighty":25.822036,"marketCap":115628981743.6},{"date":"2024-04-19","current":20.090217,"twenty":10.088339,"median":17.71521,"eighty":25.822036,"marketCap":115682634323.95},{"date":"2024-04-26","current":25.102236,"twenty":10.092665,"median":17.717104,"eighty":25.817137,"marketCap":122028864510.98},{"date":"2024-05-03","current":25.121496,"twenty":10.092665,"median":17.717104,"eighty":25.817137,"marketCap":121965711156.52},{"date":"2024-05-10","current":25.955211,"twenty":10.092665,"median":17.717104,"eighty":25.881185,"marketCap":126909542740.01},{"date":"2024-05-17","current":24.564329,"twenty":10.092665,"median":17.717104,"eighty":25.881185,"marketCap":121166222484.78},{"date":"2024-05-24","current":24.660746,"twenty":10.092665,"median":17.717104,"eighty":25.881185,"marketCap":121128331641.95},{"date":"2024-05-31","current":24.726861,"twenty":10.092665,"median":17.717104,"eighty":25.881185,"marketCap":121676961247.02},{"date":"2024-06-07","current":25.104265,"twenty":10.092665,"median":17.717104,"eighty":25.881185,"marketCap":123964258787.81},{"date":"2024-06-14","current":23.809521,"twenty":10.092665,"median":17.717104,"eighty":25.881185,"marketCap":116305279179.76},{"date":"2024-06-21","current":24.137339,"twenty":10.088339,"median":17.71521,"eighty":25.90586,"marketCap":117375957434.63},{"date":"2024-06-28","current":24.776447,"twenty":10.079688,"median":17.696545,"eighty":25.961437,"marketCap":120367749389.79},{"date":"2024-07-05","current":25.051924,"twenty":10.079688,"median":17.696545,"eighty":25.961437,"marketCap":122903385527.57},{"date":"2024-07-12","current":26.005076,"twenty":10.079688,"median":17.696545,"eighty":25.984495,"marketCap":128286809560.82},{"date":"2024-07-15","current":25.462386,"twenty":10.079688,"median":17.696545,"eighty":25.984495,"marketCap":126116902211.31},{"date":"2024-08-02","current":28.58221,"twenty":10.045539,"median":17.667431,"eighty":25.970775,"marketCap":129963975586.71},{"date":"2024-08-09","current":28.611937,"twenty":10.045539,"median":17.667431,"eighty":26.395222,"marketCap":131603672136.16},{"date":"2024-08-16","current":29.365903,"twenty":10.045539,"median":17.667431,"eighty":26.965608,"marketCap":135991482271.53},{"date":"2024-08-23","current":29.827758,"twenty":10.045539,"median":17.667431,"eighty":27.30154,"marketCap":139679917173.16},{"date":"2024-08-30","current":30.083408,"twenty":10.045539,"median":17.667431,"eighty":27.737312,"marketCap":140486982478.95},{"date":"2024-09-06","current":31.076279,"twenty":10.045539,"median":17.667431,"eighty":27.755808,"marketCap":145252320920.18},{"date":"2024-09-13","current":30.737395,"twenty":10.045539,"median":17.667431,"eighty":28.017403,"marketCap":143002491189.58},{"date":"2024-09-20","current":30.78296,"twenty":10.045539,"median":17.667431,"eighty":28.416222,"marketCap":144554419337.27},{"date":"2024-09-27","current":30.616469,"twenty":10.045539,"median":17.667431,"eighty":28.416222,"marketCap":144270741555.83},{"date":"2024-10-04","current":30.241865,"twenty":10.045539,"median":17.667431,"eighty":28.439522,"marketCap":140433638887.54},{"date":"2024-10-11","current":29.775602,"twenty":10.045539,"median":17.667431,"eighty":28.439522,"marketCap":137150593697.15},{"date":"2024-10-18","current":29.977793,"twenty":10.045539,"median":17.667431,"eighty":28.439522,"marketCap":136855848164.59},{"date":"2024-10-25","current":29.757762,"twenty":10.045539,"median":17.667431,"eighty":28.439522,"marketCap":135513851100.67},{"date":"2024-10-31","current":27.016329,"twenty":10.045539,"median":17.667431,"eighty":28.017403,"marketCap":132177608883.82},{"date":"2024-11-08","current":26.635368,"twenty":10.044628,"median":17.666414,"eighty":26.885017,"marketCap":129456333845.32},{"date":"2024-11-15","current":25.402919,"twenty":10.044628,"median":17.666414,"eighty":26.404422,"marketCap":121101937530.68},{"date":"2024-11-22","current":25.92038,"twenty":10.044628,"median":17.666414,"eighty":25.927346,"marketCap":122518864801.22},{"date":"2024-11-29","current":25.619919,"twenty":10.044628,"median":17.666414,"eighty":25.699083,"marketCap":121788536423.67},{"date":"2024-12-06","current":25.644957,"twenty":10.044628,"median":17.666414,"eighty":25.611269,"marketCap":122139495847.16},{"date":"2024-12-13","current":24.807559,"twenty":10.044628,"median":17.666414,"eighty":25.528111,"marketCap":117246552266.62},{"date":"2024-12-20","current":25.394572,"twenty":10.044628,"median":17.666414,"eighty":25.504351,"marketCap":118799775303.16},{"date":"2024-12-27","current":25.950983,"twenty":10.044628,"median":17.666414,"eighty":25.504351,"marketCap":121782054794.83},{"date":"2025-01-03","current":25.836919,"twenty":10.044628,"median":17.666414,"eighty":25.504351,"marketCap":119394068299.66},{"date":"2025-01-10","current":26.476134,"twenty":10.043718,"median":17.662753,"eighty":25.478661,"marketCap":122813940759.73},{"date":"2025-01-17","current":27.190583,"twenty":10.043718,"median":17.662753,"eighty":25.478661,"marketCap":126128028900.56},{"date":"2025-01-24","current":27.736112,"twenty":10.043718,"median":17.662753,"eighty":25.478661,"marketCap":130118603784.49},{"date":"2025-01-31","current":22.679241,"twenty":10.043718,"median":17.662753,"eighty":25.458421,"marketCap":135796476672.57},{"date":"2025-02-07","current":22.453317,"twenty":10.043718,"median":17.662753,"eighty":25.395685,"marketCap":133815994648.27},{"date":"2025-02-14","current":22.527177,"twenty":10.043718,"median":17.662753,"eighty":25.302609,"marketCap":135139535422.45},{"date":"2025-02-21","current":23.475533,"twenty":10.043718,"median":17.662753,"eighty":25.274251,"marketCap":136588490535.79},{"date":"2025-02-28","current":23.529645,"twenty":10.043718,"median":17.662753,"eighty":25.156716,"marketCap":136134051560.87},{"date":"2025-03-07","current":24.715596,"twenty":10.042807,"median":17.659092,"eighty":25.048936,"marketCap":148818188841.24},{"date":"2025-03-14","current":23.949012,"twenty":10.042807,"median":17.659092,"eighty":24.864048,"marketCap":144656712656.17},{"date":"2025-03-21","current":23.863334,"twenty":10.042807,"median":17.659092,"eighty":24.801725,"marketCap":143967164905.6},{"date":"2025-03-28","current":22.763528,"twenty":10.042807,"median":17.659092,"eighty":24.715596,"marketCap":136620485714.59},{"date":"2025-04-04","current":21.134417,"twenty":10.042807,"median":17.659092,"eighty":24.626125,"marketCap":130072347841.49},{"date":"2025-04-11","current":19.729859,"twenty":10.043718,"median":17.662753,"eighty":24.453364,"marketCap":122690991838.72},{"date":"2025-04-17","current":19.969823,"twenty":10.043718,"median":17.662753,"eighty":24.305248,"marketCap":126259056108.71},{"date":"2025-04-25","current":17.94759,"twenty":10.042807,"median":17.659092,"eighty":24.198495,"marketCap":128365926735.55},{"date":"2025-04-28","current":18.091389,"twenty":10.042807,"median":17.659092,"eighty":24.157724,"marketCap":129659412412.11}],"updateTime":1745928132868}}}